532296:BOM
Glenmark Pharmaceuticals Ltd
₹ 2,224.00
arrow_downward
-1.17%(-26.30) Siku 1
16 Okt, 15:30:00 GMT +5:30 · INR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 532296...
Fungua
₹ 2,249.80
Juu
₹ 2,264.00
Chini
₹ 2,224.00
Mtaji wa soko
628.43B
Wastani wa kiasi cha mauzo
elfu 17.97
Kiasi cha mauzo ya hisa
elfu 12.94
Gawio
0.22%
Mgawo wa faida wa kila robo mwaka
₹ 1.25
Tarehe ya kutojumuisha gawio
3 Okt 2025
Uwiano wa bei ya hisa na mapato kwa kila hisa
34.92
Juu kwa wiki 52
₹ 2,536.85
Chini kwa wiki 52
₹ 1,794.00
EPS
₹ 63.68
Hisa za wawekezaji
0.00
Idadi ya wafanyakazi
elfu 17
Fungua
₹ 2,249.80
Juu
₹ 2,264.00
Chini
₹ 2,224.00
Mtaji wa soko
628.43B
Wastani wa kiasi cha mauzo
elfu 17.97
Kiasi cha mauzo ya hisa
elfu 12.94
Gawio
0.22%
Mgawo wa faida wa kila robo mwaka
₹ 1.25
Tarehe ya kutojumuisha gawio
3 Okt 2025
Uwiano wa bei ya hisa na mapato kwa kila hisa
34.92
Juu kwa wiki 52
₹ 2,536.85
Chini kwa wiki 52
₹ 1,794.00
EPS
₹ 63.68
Hisa za wawekezaji
0.00
Idadi ya wafanyakazi
elfu 17
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Business Wire
·
dakika 28 zilizopita
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
dakika 58 zilizopita
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
·
dakika 58 zilizopita
Kopin to Host Live YouTube "Ask Me Anything" Panel from Nasdaq MarketSite on the Future of AI Infrastructure
CNN
·
saa 2 zilizopita
Nasdaq sinks more than 2% as investors raise questions about AI debt
Wasifu
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
Kuhusu Glenmark Pharmaceuticals Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 16.9
Lilianzishwa1977
Makao makuu-
Sekta-
Tovutiglenmarkpharma.com